EGCGEpigallocatechin-3-gallateAlzheimer’s diseasevascular dementiaC57BL/6J
… group (p=0.02); Filter+BCAS (p<0.001); and DEP+BCAS (p=0.001). EGCG treatment suppressed these effects.Conclusion EGCG therapy show…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Epigallocatechin-3-gallate ×
Epigallocatechin-3-gallate
This drug is selected. Its supporting articles are shown below.